Back to Search Start Over

IPR-166: a potent and selective prolyl oligopeptidase inhibitor ameliorates cognitive symptoms associated to schizophrenia after oral administration

Authors :
Roger Prades
Teresa Tarragó
Eva Munarriz-Cuezva
J. Javier Meana
Leyre Urigüen
Source :
European Neuropsychopharmacology. 29:S244
Publication Year :
2019
Publisher :
Elsevier BV, 2019.

Details

ISSN :
0924977X
Volume :
29
Database :
OpenAIRE
Journal :
European Neuropsychopharmacology
Accession number :
edsair.doi...........e3bfcd031c3a353579f6481a6f96dec4
Full Text :
https://doi.org/10.1016/j.euroneuro.2018.11.390